Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:2226-2231
Published online before print November 13, 2006, doi: 10.1161/CIRCULATIONAHA.106.622340
CLINICAL PERSPECTIVE
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/21/2226    most recent
CIRCULATIONAHA.106.622340v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, T. T.
Related Collections
Right arrow Health policy and outcome research
Right arrow Other Research
Right arrowRelated Article

(Circulation. 2006;114:2226-2231.)
© 2006 American Heart Association, Inc.


Health Services and Outcomes Research

Long-Term Survival in Patients Presenting With Type B Acute Aortic Dissection

Insights From the International Registry of Acute Aortic Dissection

Thomas T. Tsai, MD; Rossella Fattori, MD; Santi Trimarchi, MD; Eric Isselbacher, MD; Truls Myrmel, MD; Arturo Evangelista, MD; Stuart Hutchison, MD; Udo Sechtem, MD; Jeanna V. Cooper, MS; Dean E. Smith, PhD; Linda Pape, MD; James Froehlich, MD; Arun Raghupathy, MD; James L. Januzzi, MD; Kim A. Eagle, MD; Christoph A. Nienaber, MD, on behalf of the International Registry of Acute Aortic Dissection (IRAD)

From Department of Internal Medicine (T.T.T., J.V.C., D.E.S., J.F., A.R., K.A.E.), Division of Cardiology, University of Michigan Medical Center, Ann Arbor, Mich; University Hospital S. Orsola (R.F.), Bologna, Italy; Istituto Policlinico San Donato (S.T.), San Donato, Italy; University of Rostock (C.A.N.), Rostock, Germany; Tromsø University Hospital (T.M.), Tromsø, Norway; Hospital General Universitari Vall d’Hebron (A.E.), Barcelona, Spain; St. Michael’s Hospital (S.H.), Toronto, Ontario, Canada; Robert-Bosch Krankenhaus (U.S.), Stuttgart, Germany; University of Massachusetts Hospital (L.P.), Worcester, Mass; and Massachusetts General Hospital (J.L.J., E.I.), Boston, Mass.

Correspondence to Thomas T. Tsai, MD, University of Michigan Medical Center, 24 Frank Lloyd Wright Dr, Lobby A, Room #3201, PO Box 384, Ann Arbor, MI 48106-0384. E-mail hsianshi{at}umich.edu

Received February 22, 2006; revision received September 11, 2006; accepted September 13, 2006.


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background— Follow-up survival studies in patients with acute type B aortic dissection have been restricted to a small number of patients in single centers. We used data from a contemporary registry of acute type B aortic dissection to better understand factors associated with adverse long-term survival.

Methods and Results— We examined 242 consecutive patients discharged alive with acute type B aortic dissection enrolled in the International Registry of Acute Aortic Dissection (IRAD) between 1996 and 2003. Kaplan-Meier survival curves were constructed, and Cox proportional hazards analysis was performed to identify independent predictors of follow-up mortality. Three-year survival for patients treated medically, surgically, or with endovascular therapy was 77.6±6.6%, 82.8±18.9%, and 76.2±25.2%, respectively (median follow-up 2.3 years, log-rank P=0.61). Independent predictors of follow-up mortality included female gender (hazard ratio [HR],1.99; 95% confidence interval [CI], 1.07 to 3.71; P=0.03), a history of prior aortic aneurysm (HR, 2.17; 95% CI, 1.03 to 4.59; P=0.04), a history of atherosclerosis (HR, 2.48; 95% CI, 1.32 to 4.66; P<0.01), in-hospital renal failure (HR, 2.55; 95% CI, 1.15 to 5.63; P=0.02), pleural effusion on chest radiograph (HR, 2.56; 95% CI, 1.18 to 5.58; P=0.02), and in-hospital hypotension/shock (HR, 12.5; 95% CI, 3.24 to 48.21; P<0.01).

Conclusions— Contemporary follow-up mortality in patients who survive to hospital discharge with acute type B aortic dissection is high, approaching 1 in every 4 patients at 3 years. Current treatment and follow-up surveillance require further study to better understand and optimize care for patients with this complex disease.


Key Words: aorta • risk factors • mortality • follow-up studies


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
In-hospital outcomes are generally acceptable in patients with uncomplicated acute type B dissection, 90% of whom survive to hospital discharge after receiving effective antihypertensive therapy.1 In patients presenting with evolving complications such as signs of imminent rupture, expansion, retrograde dissection, or malperfusion syndromes, however, classic open surgery for acute type B aortic dissection carries a 14% to 67% risk of irreversible spinal injury or postoperative mortality.2–4 Over the last 10 years, endovascular techniques including fenestration and stent grafting have emerged as less invasive alternatives to surgery in patients with complicated type B dissections and have been reported to translate into better short-term outcomes.5–7

Clinical Perspective p 2231

Short- and long-term prognosis after discharge from the hospital for acute type B dissection remains unclear. Previous studies are inconsistent and have reported survival rates between 56% and 92% at 1 year and 48% to 82% at 5 years.8–15 However, most of these studies were single-center experiences with enrollment periods spanning decades and excluded patients treated with endovascular therapies. This lack of contemporary data on survival, as well as improved surgical techniques and the advent of new endovascular therapies such as stenting and fenestration, has led to the need to reassess optimal therapy for acute type B aortic dissection and evaluate how patients currently fare after hospital discharge.

The International Registry of Acute Aortic Dissection (IRAD) currently represents 21 large referral centers from around the world with consecutively enrolled patients presenting with acute type B aortic dissection. It includes clinical information on in-hospital clinical outcomes and follow-up data. Investigators and in-hospital covariates are listed in the appendices, which are found in the online-only Data Supplement. The purpose of the present study was to evaluate long-term survival rates in a contemporary registry of acute type B aortic dissection after hospital discharge and to report the clinical correlates of death based on in-hospital presentation and complications.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
IRAD is a multinational registry of 21 referral centers in 11 countries designed to provide an unbiased representative population of patients with acute aortic dissection. Treatment during the index hospitalization or in follow-up was not standardized but was at the discretion of each patient’s treating physician. Full details of the IRAD structure and methods used have been published previously.1,16

Study Population
We examined data on all patients with acute type B aortic dissection enrolled in IRAD between January 1, 1996, and December 31, 2003. Acute type B aortic dissection was defined as any nontraumatic dissection that involved the descending aorta and that appeared within 14 days of symptom onset.17,18 Patients were identified prospectively at presentation or retrospectively via discharge diagnoses, imaging, and surgical databases. Diagnosis was based on confirmatory imaging, intraoperative visualization, or autopsy.

Of the 1417 patients enrolled in IRAD with acute aortic dissection, 532 (37.5%) had type B dissections. To minimize bias with regard to differences in follow-up, the present study included 317 patients (59.6%) from the 8 of 15 referral centers with >80% follow-up, of whom 39 (12.3%) died in the hospital. The remaining 242 (87.1%) had follow-up death data and comprised the present study population. Median follow-up time was 2.3 years.

Data Collection
Clinical variables were recorded on a standardized form that included information on patient demographics, history, clinical presentation, physical findings, imaging study results, details of medical and surgical treatment, and patient outcomes, including mortality. Completed data entry forms were forwarded to the IRAD data coordinating center at the University of Michigan and reviewed for internal consistency and face validity and then scanned electronically into an Access database (Microsoft Corp, Redmond, Wash).

Yearly follow-up data were obtained up to 5 years after discharge with standardized forms. Collected data included variables on clinical, imaging, and mortality data. When applicable, missing data on mortality were obtained through the Social Security Death Index. At each enrolling hospital, study investigators worked with their ethics or institutional review board to obtain appropriate approval to participate.

Statistical Analysis
We compared patients by in-hospital management. Summary statistics between the 3 groups are presented as frequencies for categorical variables and mean±SD for continuous variables. In all cases, missing data were not defaulted to negative, and denominators reflect only cases reported. Relationships with follow-up death were investigated with univariate Cox regression analysis. Stepwise Cox proportional hazards analysis was performed to identify independent predictors of follow-up mortality. Initial modeling used variables marginally suggestive of an unadjusted association with follow-up mortality (P<0.20; Appendix 2). Variables were reviewed for clinical significance before testing. Ascending stepwise selection of variables after controlling for age, gender, and in-hospital management were performed sequentially, with a default value for inclusion set at P<0.05. The estimated survival function for the fitted model was used to construct predicted survival curves for each predictor, with sample mean values used for the remaining covariates. SAS version 8.2 (SAS Institute, Cary, NC) and Stata version 8.0 (StataCorp LP, College Station, Tex) were used for analyses.

The authors had full access to the data and take full responsibility for its integrity. All authors have read and agree to the manuscript as written.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Study Population, Baseline Characteristics, and Differences Between Groups
The mean age was 62.1±12.9 years, with the majority of patients being male (69%); 77 (32%) were aged 70 years or older, and 170 (71%) had a history of hypertension. Other comorbidities such as atherosclerosis (29%), a prior aortic aneurysm (16%), and a prior aortic dissection (7%) were not uncommon. Compared with patients receiving medical therapy alone, patients undergoing surgery or endovascular treatment were significantly more likely to have in-hospital complications such as mesenteric ischemia, extension of dissection, and limb ischemia (Table 1). Arch involvement and hypotension or shock on admission occurred significantly more often in the patients treated with surgery.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Clinical, Imaging, and In-Hospital Complications According to Management

In-Hospital Management and Outcomes
All patients were initially subjected to intense medical therapy that focused on blood pressure lowering; of these, 189 patients (78%) continued to receive medical therapy for treatment of their acute type B aortic dissection, whereas 26 (11%) underwent surgery, and 27 (11%) received endovascular treatment. The reason for endovascular or surgical treatment was documented in 88% of cases. Recurrent pain, extension of dissection, or refractory hypertension was cited as the reason in 26% of cases, whereas limb ischemia and visceral ischemia were cited in 28% and 30% of cases, respectively. Refractory pain was cited least often (13% of cases). Of the 317 patients from centers with >80% follow-up, in hospital mortality was 12 (29%) of 41 patients treated with surgery, 4 (11%) of 36 patients treated with endovascular treatment, and 23 (10%) of 240 patients treated with medical therapy alone (P<0.001). Total in-hospital mortality was 39 (12%) of 317 patients.

Figure 1 shows the survival curves estimated by the Kaplan-Meier method stratified by in-hospital management. The unadjusted survival rate at 1 and 3 years for patients discharged from the hospital alive was 90.3±4.3% and 77.6±6.6% for medical therapy alone, 95.8±8.0% and 82.8±18.9% for surgery, and 88.9±11.9% and 76.2±25.2% for endovascular treatment (median 2.3 years, log-rank P=0.63).


Figure 1179365
View larger version (17K):
[in this window]
[in a new window]
 
Figure 1. Unadjusted Kaplan-Meier survival curve stratified by in-hospital management.

Predictors of Follow-Up Mortality
Table 2 presents the univariate Cox regression analyses relating likelihood of death according to demographic, historical, and in-hospital patient variables.


View this table:
[in this window]
[in a new window]
 
TABLE 2. Univariate Cox Regression Analysis Predicting Death on the Basis of Demographic, Historical, and In-Hospital Patient Variables

Independent Predictors of Follow-Up Mortality
Cox proportional hazards analysis adjusted for age (≥70 years old), gender, and in-hospital management identified female gender (hazard ratio [HR], 1.99; 95% CI, 1.07 to 3.71; P=0.03), a history of prior aortic aneurysm (HR, 2.17; 95% CI, 1.03 to 4.59; P=0.04), a history of atherosclerosis (HR, 2.48; 95% CI, 1.32 to 4.66; P<0.01), in-hospital renal failure (HR, 2.55; 95% CI, 1.15 to 5.63; P=0.02), pleural effusion on chest radiograph (HR, 2.56; 95% CI, 1.18 to 5.58; P=0.02), and in-hospital hypotension/shock (HR, 12.5; 95% CI, 3.24 to 48.21; P<0.01) as significant independent predictors of follow-up mortality (Table 3).19


View this table:
[in this window]
[in a new window]
 
TABLE 3. Independent Predictors of Death After Multivariate Cox Regression Adjustment


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Mortality Rates in Patients With Acute Type B Aortic Dissection
This report shows that follow-up mortality rates are relatively high in patients discharged alive from the hospital after acute type B aortic dissection, approaching 1 in 4 patients dying within 3 years. Follow-up mortality after type B dissection exceeds the follow-up mortality seen after acute type A aortic dissection and exceeds the cumulative incidence of mortality in other diseases such as coronary artery disease, moderate chronic obstructive pulmonary disease, and stage II colon cancer.20,21 Furthermore, even though the present study fails to provide full information on cause-specific mortality, previous studies have suggested that 31% to 66% of follow-up deaths are due to aorta-related complications such as rupture, extension of dissection, and perioperative mortality from subsequent aortic or vascular repairs.8–10,15

The present survival analysis differs from the previous literature. Other investigators have used methods in which survival curves began at hospital admission and included both in-hospital mortality and mortality after discharge.8–15,22 In contrast, the survival curve in the present study began on the day of hospital discharge. This allowed us to focus on the impact of in-hospital variables on subsequent outcomes without including those who died in the hospital.

The design of the present analysis also allowed us to investigate the potential impact of surgery, any endovascular technique (fenestration and/or stenting), or medical therapy alone on follow-up outcomes. Previous reports have shown significant differences with respect to in-hospital mortality stratified by type of treatment for patients with acute type B aortic dissection. IRAD reported an in-hospital mortality rate of 32% for those treated with surgery, 7% for those managed with endovascular techniques, and 10% for those managed with medical therapy alone (P<0.0001).19 Despite these differences for in-hospital mortality, in-hospital management by surgery, endovascular procedures, or medical therapy alone does not appear to impact long-term survival in patients who survive to hospital discharge (Figure 1; Table 3).

Predictors of Follow-Up Mortality in Patients With Acute Type B Aortic Dissections
The present analysis identified several clinical variables as important predictors of follow-up death in patients with acute type B aortic dissection (Table 3). Similar to previous studies reporting on in-hospital and follow-up predictors of mortality, markers of malperfusion or rupture such as renal failure, hypotension, and shock were significant independent predictors of follow-up death in the present study.12,15,19

Evidence of a pleural effusion on chest radiograph was also found to be an independent predictor of follow-up mortality.23 We speculate that the presence of a pleural effusion on chest radiograph may be an indication that a periaortic hematoma has complicated the acute dissection, which may herald the possibility of rupture. This corroborates previous findings in IRAD of periaortic hematoma as an independent predictor of in-hospital mortality for acute aortic dissections.23

Not surprisingly, female gender, with age adjustment, was also an independent predictor of follow-up death in the present analysis, which is in line with the existing literature on other cardiovascular disorders and that on acute aortic dissection.24,25 IRAD has previously reported on the gender-related differences in acute aortic dissection and showed that women had a significant delay in presentation to the hospital and a higher in-hospital and surgical perioperative mortality than men.25 Finally, comorbidities such as atherosclerosis and a diseased aneurysmatic aorta have been shown in previous studies to predict in-hospital and follow-up outcomes. These factors also appear to predict perioperative mortality and all-cause mortality and morbidity.11,15 Patency of the false lumen has been implicated as a significant predictor of both aneurysm expansion and outcomes in aortic dissection. Progressive enlargement of the false lumen by 3.3 mm/y has been observed even in stable, uncomplicated type B cases.26 Owing to a paucity of imaging data on the false lumen from the index hospitalization in the present cohort, we did not examine this variable for the purposes of this report.

Figure 2 shows the predicted impact of each clinical covariate on follow-up survival. In-hospital variables such as pleural effusion on chest radiograph, in-hospital renal failure, and hypotension/shock appear to have a stronger impact on follow-up survival than predisposing risk factors such as gender and a history of atherosclerosis or a previous aortic aneurysm. Therefore, although initial in-hospital management appeared to stabilize these serious hemodynamic and end-organ insults, such complications still negatively impacted patient survival after hospital discharge.


Figure 2179365
View larger version (22K):
[in this window]
[in a new window]
 
Figure 2. Impact of clinical predictors on estimated survival. KAA indicates history of known aortic aneurysm; Hx Ath, history of atherosclerosis (coronary, peripheral, or cerebrovascular disease); Renal Failure, in-hospital acute renal failure; CX PE, pleural effusion on chest radiograph; and Hypotension/Shock, systolic blood pressure <100 mm Hg.

Differences From Prior Studies
IRAD represents the largest reported cohort of patients with acute aortic dissection and represents consecutive patients treated at tertiary referral centers with an expertise and interest in acute aortic dissection. The patients described in the present report represent 15 referral centers with patients enrolled between 1996 and 2003. Previous reports on acute type B aortic dissection were typically single-center registries spanning decades of enrollment and either predated or excluded patients managed with endovascular techniques.8–15,22 In contrast, the present study cohort represents a contemporary reflection of patients from a broad geographic region and may more accurately represent the results of using advanced imaging and the more widespread use of endovascular techniques. Furthermore, by presenting our survival analysis and multivariate models based on patients who survive to hospital discharge, we focus exclusively on predictors of follow-up mortality and the impact of in-hospital treatment strategies on follow-up outcomes.

Implications for Management
The optimal treatment of patients with acute type B aortic dissection will continue to be debated. Predictors of in-hospital morbidity and mortality such as signs of malperfusion or imminent rupture should continue to dictate in-hospital treatment decisions. Unsettled indications for active interventions, differing expertise, patient selection, and insufficient power make direct comparisons between surgery and endovascular techniques difficult. The present analysis provides predictors of follow-up mortality after successful in-hospital treatment that may have implications for subsequent imaging protocols and management considerations, however.

Study Limitations
The findings of the present study may not be generalizable to patients treated in community hospitals, because we only included patients treated at IRAD centers. Of these patients, 70% were transferred to an IRAD center from another hospital. Therefore, the majority of the present cohort reflects patients who survived the initial emergency triage and transfer period and may not be representative of patients treated directly. Furthermore, to minimize selection bias, we only included patients from the 8 of 15 centers with >80% follow-up. However, these patients resembled those from the centers with <80% follow-up with regard to mortality rates (33% versus 26%, P=0.17). Additionally, there was not a significant difference in the percentage of patients lost to follow-up when grouped according to medical, surgery, and endovascular therapy (13% versus 10% versus 16%, P=0.83). This suggests a nondifferential loss to follow-up between groups and therefore limits the bias attributable to any particular group. The unbalanced sample of patients in the endovascular (n=27) and surgical (n=26) groups compared with the medical group (n=189), however, challenges the power of the present study to detect differences in survival between treatment modalities. Finally, data available to us on follow-up mortality did not include information on cause of death. We were therefore unable to evaluate cause-specific mortality or other end points such as freedom from reoperation, rupture, or redissection.

Conclusions
Contemporary follow-up mortality in patients with acute type B aortic dissection who survive to hospital discharge is high, approaching 1 in every 4 patients at 3 years despite access to and availability of modern therapeutic strategies. Current management and follow-up strategies are yielding unsatisfactory results, and there is a need to evaluate other therapeutic and surveillance strategies.


*    Acknowledgments
 
Sources of Funding

Thomas T. Tsai is supported by a training grant from the National Institutes of Health (No. 5T32HL007853-08). IRAD has been supported by grants from the University of Michigan Faculty Group Practice and the Varbedian Fund for Research in Aortic Diseases.

Disclosures

None.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Hagan PG, Nienaber CA, Isselbacher EM, Bruckman D, Karavite DJ, Russman PL, Evangelista A, Fattori R, Suzuki T, Oh JK, Moore AG, Malouf JF, Pape LA, Gaca C, Sechtem U, Lenferink S, Deutsch HJ, Diedrichs H, Marcos y Robles J, Llovet A, Gilon D, Das SK, Armstrong WF, Deeb GM, Eagle KA. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000; 283: 897–903.[Abstract/Free Full Text]
  2. Glower DD, Fann JI, Speier RH, Morrison L, White WD, Smith LR, Rankin JS, Miller DC, Wolfe WG. Comparison of medical and surgical therapy for uncomplicated descending aortic dissection. Circulation. 1990; 82 (suppl V): IV-39–IV-46.[Medline] [Order article via Infotrieve]
  3. Svensson LG, Crawford ES, Hess KR, Coselli JS, Safi HJ. Dissection of the aorta and dissecting aortic aneurysms: improving early and long-term surgical results. Circulation. 1990; 82 (suppl V): IV-24–IV-38.[Medline] [Order article via Infotrieve]
  4. Miller DC. The continuing dilemma concerning medical versus surgical management of patients with acute type B dissections. Semin Thorac Cardiovasc Surg. 1993; 5: 33–46.[Medline] [Order article via Infotrieve]
  5. Eggebrecht H, Nienaber CA, Neuhauser M, Baumgart D, Kische S, Schmermund A, Herold U, Rehders TC, Jakob HG, Erbel R. Endovascular stent-graft placement in aortic dissection: a meta-analysis. Eur Heart J. 2006; 27: 384–385.[Free Full Text]
  6. Dake MD, Kato N, Mitchell RS, Semba CP, Razavi MK, Shimono T, Hirano T, Takeda K, Yada I, Miller DC. Endovascular stent-graft placement for the treatment of acute aortic dissection. N Engl J Med. 1999; 340: 1546–1552.[Abstract/Free Full Text]
  7. Nienaber CA, Fattori R, Lund G, Dieckmann C, Wolf W, von Kodolitsch Y, Nicolas V, Pierangeli A. Nonsurgical reconstruction of thoracic aortic dissection by stent-graft placement. N Engl J Med. 1999; 340: 1539–1545.[Abstract/Free Full Text]
  8. Elefteriades JA, Lovoulos CJ, Coady MA, Tellides G, Kopf GS, Rizzo JA. Management of descending aortic dissection. Ann Thorac Surg. 1999; 67: 2002–2005.[Abstract/Free Full Text]
  9. Bernard Y, Zimmermann H, Chocron S, Litzler JF, Kastler B, Etievent JP, Meneveau N, Schiele F, Bassand JP. False lumen patency as a predictor of late outcome in aortic dissection. Am J Cardiol. 2001; 87: 1378–1382.[CrossRef][Medline] [Order article via Infotrieve]
  10. Gysi J, Schaffner T, Mohacsi P, Aeschbacher B, Althaus U, Carrel T. Early and late outcome of operated and non-operated acute dissection of the descending aorta. Eur J Cardiothorac Surg. 1997; 11: 1163–1169.[Abstract]
  11. Haverich A, Miller DC, Scott WC, Mitchell RS, Oyer PE, Stinson EB, Shumway NE. Acute and chronic aortic dissections: determinants of long-term outcome for operative survivors. Circulation. 1985; 72 (suppl III): II-22–II-34.[Medline] [Order article via Infotrieve]
  12. Glower DD, Speier RH, White WD, Smith LR, Rankin JS, Wolfe WG. Management and long-term outcome of aortic dissection. Ann Surg. 1991; 214: 31–41.[Medline] [Order article via Infotrieve]
  13. Lansman SL, McCullough JN, Nguyen KH, Spielvogel D, Klein JJ, Galla JD, Ergin MA, Griepp RB. Subtypes of acute aortic dissection. Ann Thorac Surg. 1999; 67: 1975–1978.[Abstract/Free Full Text]
  14. Schor JS, Yerlioglu ME, Galla JD, Lansman SL, Ergin MA, Griepp RB. Selective management of acute type B aortic dissection: long-term follow-up. Ann Thorac Surg. 1996; 61: 1339–1341.[Abstract/Free Full Text]
  15. Umana JP, Lai DT, Mitchell RS, Moore KA, Rodriguez F, Robbins RC, Oyer PE, Dake MD, Shumway NE, Reitz BA, Miller DC. Is medical therapy still the optimal treatment strategy for patients with acute type B aortic dissections? J Thorac Cardiovasc Surg. 2002; 124: 896–910.[Abstract/Free Full Text]
  16. Mehta RH, O’Gara PT, Bossone E, Nienaber CA, Myrmel T, Cooper JV, Smith DE, Armstrong WF, Isselbacher EM, Pape LA, Eagle KA, Gilon D. Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era. J Am Coll Cardiol. 2002; 40: 685–692.[Abstract/Free Full Text]
  17. Daily PO, Trueblood HW, Stinson EB, Wuerflein RD, Shumway NE. Management of acute aortic dissections. Ann Thorac Surg. 1970; 10: 237–247.[Medline] [Order article via Infotrieve]
  18. Ehrlich M, Fang WC, Grabenwoger M, Cartes-Zumelzu F, Wolner E, Havel M. Perioperative risk factors for mortality in patients with acute type A aortic dissection. Circulation. 1998; 98 (suppl II): II-294–II-298.[Medline] [Order article via Infotrieve]
  19. Suzuki T, Mehta RH, Ince H, Nagai R, Sakomura Y, Weber F, Sumiyoshi T, Bossone E, Trimarchi S, Cooper JV, Smith DE, Isselbacher EM, Eagle KA, Nienaber CA. Clinical profiles and outcomes of acute type B aortic dissection in the current era: lessons from the International Registry of Aortic Dissection (IRAD). Circulation. 2003; 108 (suppl I): II-312–II-317.[Medline] [Order article via Infotrieve]
  20. Tsai TT, Evangelista A, Nienaber CA, Trimarchi S, Sechtem U, Fattori R, Myrmel T, Pape L, Cooper JV, Smith DE, Fang J, Isselbacher E, Eagle KA. Long-term survival in patients presenting with type A acute aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD). Circulation. 2006; 114 (suppl I): I-350–I-356.[Medline] [Order article via Infotrieve]
  21. Chiappini B, Schepens M, Tan E, Dell’ Amore A, Morshuis W, Dossche K, Bergonzini M, Camurri N, Reggiani LB, Marinelli G, Di Bartolomeo R. Early and late outcomes of acute type A aortic dissection: analysis of risk factors in 487 consecutive patients. Eur Heart J. 2005; 26: 180–186.[Abstract/Free Full Text]
  22. Marui A, Mochizuki T, Mitsui N, Koyama T, Kimura F, Horibe M. Toward the best treatment for uncomplicated patients with type B acute aortic dissection: a consideration for sound surgical indication. Circulation. 1999; 100 (suppl II): II-275–II-80.[Medline] [Order article via Infotrieve]
  23. Mukherjee D, Evangelista A, Nienaber CA, Sechtem U, Suzuki T, Trimarchi S, Llovet A, Myrmel T, O’Gara PT, Fang J, Cooper JV, Oh JK, Januzzi JL, Hutchison S, Fattori R, Pape LA, Isselbacher EM, Eagle KA. Implications of periaortic hematoma in patients with acute aortic dissection (from the International Registry of Acute Aortic Dissection). Am J Cardiol. 2005; 96: 1734–1738.[CrossRef][Medline] [Order article via Infotrieve]
  24. Nabel EG, Selker HP, Califf RM, Canto JG, Cao JJ, Desvigne-Nikkens P, Goldberg RJ, Finnegan JR Jr, Vaccarino V, Virmani R. Women’s Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2–4, 2002: section 3: diagnosis and treatment of acute cardiac ischemia: gender issues. Circulation. 2004; 109: e50–e52.[Medline] [Order article via Infotrieve]
  25. Nienaber CA, Fattori R, Mehta RH, Richartz BM, Evangelista A, Petzsch M, Cooper JV, Januzzi JL, Ince H, Sechtem U, Bossone E, Fang J, Smith DE, Isselbacher EM, Pape LA, Eagle KA. Gender-related differences in acute aortic dissection. Circulation. 2004; 109: 3014–3021.[Abstract/Free Full Text]
  26. Sueyoshi E, Sakamoto I, Hayashi K, Yamaguchi T, Imada T. Growth rate of aortic diameter in patients with type B aortic dissection during the chronic phase. Circulation. 2004; 110 (suppl II): II-256–II-261.[Medline] [Order article via Infotrieve]

 

CLINICAL PERSPECTIVE

Patients with acute type B aortic dissection generally have acceptable in-hospital survival rates if their hospital course is not complicated by aortic expansion, retrograde dissection, or malperfusion syndromes. Long-term outcome once a patient survives to hospital discharge, however, is not well known. Using data from the International Registry of Acute Aortic Dissection, we found that contemporary follow-up mortality is high, approaching 1 in every 4 patients at 3 years despite access to and availability of modern therapeutic and imaging strategies. Female gender, history of aortic aneurysm or atherosclerosis, and in-hospital complications such as renal failure, pleural effusion, or shock independently predicted follow-up mortality; however, type of management (surgery, endovascular therapy, or medical therapy alone) did not significantly impact the risk of follow-up mortality. This report emphasizes the need to evaluate other therapeutic and surveillance strategies to improve long-term survival in patients with type B aortic dissection.


*    Footnotes
 
Presented in part at the 78th Annual Scientific Sessions of the American Heart Association, Dallas, Tex, November 13–16, 2005, and published in abstract form (Circulation. 2005;112[suppl II]:II-535).

The online-only Data Supplement, which includes a listing of IRAD investigators, can be found at http://circ.ahajournals.org/cgi/content/full/CIRCULATIONAHA.106.622340/DC1.


Related Article:

Issue Highlights
Circulation 2006 114: 2199. [Full Text]



This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
W. Y. Szeto, M. McGarvey, A. Pochettino, G. W. Moser, A. Hoboken, K. Cornelius, E. Y. Woo, J. P. Carpenter, R. M. Fairman, and J. E. Bavaria
Results of a new surgical paradigm: endovascular repair for acute complicated type B aortic dissection.
Ann. Thorac. Surg., July 1, 2008; 86(1): 87 - 94.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
T. Shimokawa, K. Horiuchi, N. Ozawa, K. Fumimoto, S. Manabe, T. Tobaru, and S. Takanashi
Outcome of surgical treatment in patients with acute type B aortic dissection.
Ann. Thorac. Surg., July 1, 2008; 86(1): 103 - 107.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
W. Swee and M. D. Dake
Endovascular Management of Thoracic Dissections
Circulation, March 18, 2008; 117(11): 1460 - 1473.
[Full Text] [PDF]


Home page
PERSPECT VASC SURG ENDOVASC THERHome page
Jae Sung Cho and M. S. Makaroun
Tsai TT, Fattori R, Trimarchi S, et al. Long-term survival in patients presenting with type B acute aortic dissection: insights from the International Registry of Acute Aortic Dissection. Circulation. 2006;114: 2226-2231
Perspectives in Vascular Surgery and Endovascular Therapy, March 1, 2008; 20(1): 95 - 96.
[Abstract] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. Nakahira, H. Ogino, H. Matsuda, K. Minatoya, H. Sasaki, J. Kobayashi, T. Yagihara, and S. Kitamura
Postural change causing leg malperfusion resulting from expansion of a patent false lumen in type B aortic dissection.
J. Thorac. Cardiovasc. Surg., October 1, 2007; 134(4): 1046 - 1047.
[Full Text] [PDF]


Home page
CirculationHome page
T. T. Tsai, E. M. Isselbacher, S. Trimarchi, E. Bossone, L. Pape, J. L. Januzzi, A. Evangelista, J. K. Oh, A. Llovet, J. Beckman, et al.
Acute Type B Aortic Dissection: Does Aortic Arch Involvement Affect Management and Outcomes?: Insights From the International Registry of Acute Aortic Dissection (IRAD)
Circulation, September 11, 2007; 116(11_suppl): I-150 - I-156.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. M. Isselbacher
Dissection of the Descending Thoracic Aorta: Looking Into the Future
J. Am. Coll. Cardiol., August 21, 2007; 50(8): 805 - 807.
[Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
114/21/2226    most recent
CIRCULATIONAHA.106.622340v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsai, T. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsai, T. T.
Related Collections
Right arrow Health policy and outcome research
Right arrow Other Research
Right arrowRelated Article